Analysts Expect CryoPort Inc (CYRX) to Announce ($0.07) Earnings Per Share

CryoPort Inc (NASDAQ:CYRX) has been assigned an average broker rating score of 1.25 (Strong Buy) from the four analysts that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a buy recommendation and three have issued a strong buy recommendation on the company. CryoPort’s rating score has improved by 6% from three months ago as a result of a number of analysts’ upgrades and downgrades.

Analysts have set a 12 month consensus price target of $11.00 for the company and are predicting that the company will post ($0.07) earnings per share for the current quarter, according to Zacks. Zacks has also assigned CryoPort an industry rank of 166 out of 265 based on the ratings given to related companies.

Several analysts have recently commented on CYRX shares. Roth Capital started coverage on shares of CryoPort in a research report on Thursday, November 30th. They issued a “buy” rating and a $12.50 price target on the stock. Janney Montgomery Scott raised their target price on shares of CryoPort from $10.00 to $12.00 and gave the stock a “buy” rating in a research report on Tuesday, October 3rd.

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Northern Trust Corp boosted its position in CryoPort by 105.0% during the second quarter. Northern Trust Corp now owns 22,179 shares of the consumer goods maker’s stock worth $109,000 after acquiring an additional 11,358 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in CryoPort during the third quarter worth approximately $118,000. Bank of Montreal Can acquired a new stake in CryoPort during the fourth quarter worth approximately $142,000. Wolverine Trading LLC acquired a new stake in CryoPort during the third quarter worth approximately $230,000. Finally, Granite Investment Partners LLC acquired a new stake in CryoPort during the third quarter worth approximately $535,000. Hedge funds and other institutional investors own 18.10% of the company’s stock.

CryoPort (NASDAQ:CYRX) opened at $8.36 on Friday. The company has a market capitalization of $214.54, a PE ratio of -16.39 and a beta of 0.99. CryoPort has a 52 week low of $1.96 and a 52 week high of $10.40.

CryoPort (NASDAQ:CYRX) last released its quarterly earnings results on Wednesday, November 1st. The consumer goods maker reported ($0.08) EPS for the quarter, meeting the consensus estimate of ($0.08). CryoPort had a negative net margin of 91.28% and a negative return on equity of 46.99%. equities research analysts predict that CryoPort will post -0.32 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece of content was first posted by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another domain, it was illegally copied and reposted in violation of international trademark & copyright legislation. The legal version of this piece of content can be accessed at

About CryoPort

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Get a free copy of the Zacks research report on CryoPort (CYRX)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for CryoPort Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort and related companies with's FREE daily email newsletter.

Leave a Reply